Canna-pharmaceutical company Kannalife Sciences has patented KLS-13019, a cannabidiol (CBD)-like compound that is actually absorbed better than CBD in the body and brain. While this is applauded as a move that will help millions with neurological disorders, is it questionable that the federal government still lists CBD as a Schedule 1 addictive drug with no medical purpose. Does the federal government criminalize CBD use only because it cannot patent CBD and make money from it? If this new drug KLS-13019 can treat 600 neurological diseases, like Kannalife suggests. shouldn’t slightly less effective CBD be allowed as treatment? Kannalife’s patent was based off research showing CBD was a target drug candidate for treating oxidative stress related disorders. Sadly Kannalife’s patent protection lasts through 2034, guaranteeing you’ll be paying a lot of money to get super CBD drug KLS-13019 exclusively from them for years.
To prep the world to like Kannalife, Hollywood brings you “Concussion,” where lead actor Will Smith plays key Kannalife scientist Dr. Bennet Omalu. Why can’t Hollywood bring us a real movie about how the government has lied to us for years about cannabis? After all, the United States government patented “Cannabinoids as Antioxidants and Neuroprotectants,” #6630507, and Kannalife holds the exclusive license with the National Institutes of Health (NIH) to commercialize it. How can the U.S. government say cannabis or natural cannabinoids like CBD have no medical benefits when they hold a patent and have heavily invested in profiting off commercially manufactured cannabinoids?
Find out how you can become a sponsor: Impact Network Sponsorship Packet
What do you think? Comment below: